secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2026-07-22T10:58:24+00:00
Accession:  0001628280-26-049103
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD EVP Mike Garrison to retire Oct. 2, 2026; BioPharma Systems to report directly to CEO
--------------------------------------------------------------------------------

- Michael D. Garrison, EVP and President of Medical Essentials and BioPharma Systems, will retire effective Oct. 2, 2026.
- Garrison will remain in his role through the end of the fiscal year to support transition.
- A comprehensive search is underway for the next President of Medical Essentials.
- BioPharma Systems segment will report directly to Chairman, CEO and President Tom Polen, streamlining the operating model.
- Garrison spent over 20 years at BD, holding leadership roles including president of Medical segment and Medication Management Solutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/0001628280-26-049103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828026049103/bdx-20260719.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-049103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer